RIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS

Ito, Yasushi, Ofengeim, Dimitry, Najafov, Ayaz, Das, Sudeshna, Saberi, Shahram, Li, Ying, Hitomi, Junichi, Zhu, Hong +13 more·2016·Science

Cited by (611)

Items 301–400 of 611

  1. Novel chemical inhibitor against SOD1 misfolding and aggregation protects neuron-loss and ameliorates disease symptoms in ALS mouse model
    Tae‐Gyun Woo, Min-Ho Yoon, So‐mi Kang, So‐Young Park, Jung-Hyun Cho, Young Jun Hwang, Jinsook Ahn, Hyewon Jang, Yun-Jeong Shin, Eui‐Man Jung et al. · 2021 · Communications Biology
  2. Inhibition of RIPK1 by ZJU-37 promotes oligodendrocyte progenitor proliferation and remyelination via NF-κB pathway
    Xiao-Ru Ma, Shuying Yang, Shuangshuang Zheng, Huanhuan Yan, Hui-Min Gu, Fan Wang, Yang Wu, Zhao-Jun Dong, Di-Xian Wang, Yue Wang et al. · 2022 · Cell Death Discovery
  3. Catching a killer: Mechanisms of programmed cell death and immune activation in Amyotrophic Lateral Sclerosis
    Dylan V. Neel, Himanish Basu, Georgia Gunner, Isaac M. Chiu · 2022 · Immunological Reviews
  4. Molecular and functional characteristics of receptor-interacting protein kinase 1 (RIPK1) and its therapeutic potential in Alzheimer's disease
    Satyam Pati, Avtar Singh Gautam, Mangaldeep Dey, Aman Tiwari, Rakesh Kumar Singh · 2023 · Drug Discovery Today
  5. Optineurin Insufficiency Disbalances Proinflammatory and Anti-inflammatory Factors by Reducing Microglial IFN-β Responses
    Andrea Markovinović, Tereza Ljutić, Louis‐Charles Béland, Ivana Munitić · 2018 · Neuroscience
  6. Gene therapy breakthroughs in ALS: a beacon of hope for 20% of ALS patients
    Qingjian Xie, Kezheng Li, Yinuo Chen, Yaojia Li, Wenhua Jiang, Wen Cao, Huan Yu, Dongsheng Fan, Binbin Deng · 2025 · Translational Neurodegeneration
  7. Necroptotic extracellular vesicles – present and future
    Yael Raden, Inbar Shlomovitz, Motti Gerlic · 2020 · Seminars in Cell and Developmental Biology
  8. Clemastine Rescues Chemotherapy-Induced Cognitive Impairment by Improving White Matter Integrity
    Yingxi Chen, Jie Sheng, Xiuying Tang, Yuhong Zhao, Shujuan Zhu, Qian Liu · 2022 · Neuroscience
  9. Diverse pathways to neuronal necroptosis in Alzheimer's disease
    Anusha Jayaraman, Richard Reynolds · 2022 · European Journal of Neuroscience
  10. Receptor-interacting protein kinase 1 (RIPK1) inhibitor: a review of the patent literature (2018-present)
    Lijuan Xu, Wannian Zhang, Chunlin Zhuang · 2023 · Expert Opinion on Therapeutic Patents
  11. Neutrophils: a subgroup of neglected immune cells in ALS
    Wen Cao, Dongsheng Fan · 2023 · Frontiers in Immunology
  12. Inflammation in Metal-Induced Neurological Disorders and Neurodegenerative Diseases
    Ruokun Wei, Peiqi Wei, Haiyan Yuan, Xiang Yi, Michael Aschner, Yue‐Ming Jiang, Shaojun Li · 2024 · Biological Trace Element Research
  13. Muscle fiber necroptosis in pathophysiology of idiopathic inflammatory myopathies and its potential as target of novel treatment strategy
    Kamiya, Mari, Kimura, Naoki, Umezawa, Natsuka, Hasegawa, Hisanori, Yasuda, Shinsuke · 2023 · Frontiers in Immunology
  14. Microglial pyroptosis drives neuropathic pain and targeting NLRP3 alleviates pain and neuroinflammation
    Juhee Shin, Junhua Wu, Hyewon Park, Song I Kim, Nara Shin, Hyo Jung Shin, Guang Ren, Jeong‐a Kim, Patrick T.J. Hwang, Ho‐Wook Jun et al. · 2025 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  15. Mechanics of a molecular mousetrap—nucleation-limited innate immune signaling
    Alejandro Rodríguez Gama, Tayla Miller, Randal Halfmann · 2021 · Biophysical Journal
  16. Identification of necroptosis-related subtypes and prognosis model in triple negative breast cancer
    Shengyu Pu, Yudong Zhou, Peiling Xie, Xiaoqian Gao, Yang Liu, Yu Ren, Jianjun He, Na Hao · 2022 · Frontiers in Immunology
  17. Screening for possible oligogenic pathogenesis in Chinese sporadic ALS patients
    Hang Zhang, Wanshi Cai, Siyu Chen, Jialong Liang, Zhanjun Wang, Yuting Ren, Wenxiu Liu, Xiaolan Zhang, Zhong Sheng Sun, Xusheng Huang · 2018 · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
  18. Advances in the regulatory mechanisms of mTOR in necroptosis
    Yawen Xie, Guoyu Zhao, Xianli Lei, Na Cui, Hao Wang · 2023 · Frontiers in Immunology
  19. A phase I randomized study to evaluate safety, pharmacokinetics, and pharmacodynamics of SIR2446M, a selective RIPK1 inhibitor, in healthy participants
    Ana Liza Andresan Sun, John Gillies, Yang Shen, Huajun Deng, Fenchao Xue, Yongfen Ma, Linan Song · 2024 · Clinical and Translational Science
  20. Discovery and Structure-Based Optimization of Fragments Binding the Mixed Lineage Kinase Domain-like Protein Executioner Domain
    Martin Rübbelke, James Y. Hamilton, Florian P. C. Binder, Margit Bauer, Jim King, Herbert Nar, Markus Zeeb · 2021 · Journal of Medicinal Chemistry
  21. Profiling of small‐molecule necroptosis inhibitors based on the subpockets of kinase–ligand interactions
    Lijuan Xu, Chunlin Zhuang · 2023 · Medicinal Research Reviews
  22. Cognitive enhancing effects of pazopanib in D‑galactose/ovariectomized Alzheimer’s rat model: insights into the role of RIPK1/RIPK3/MLKL necroptosis signaling pathway
    Rasha Abdelhady, Nancy S. Younis, Omaima Ali, Samah Shehata, Rabab Hamed Sayed, Rania I. Nadeem · 2023 · Inflammopharmacology
  23. Elevated peripheral levels of receptor-interacting protein kinase 1 (RIPK1) and IL-8 as biomarkers of human amyotrophic lateral sclerosis
    Jun Stephen Wei, Min Li, Ye Zhi, Xinqian Hu, Xiaoyan He, Jia Wang, Gaofeng Chen, Chengyu Zou, Daichao Xu, Hongbing Zhang et al. · 2023 · Signal Transduction and Targeted Therapy
  24. Practical Three-Component Regioselective Synthesis of Drug-Like 3-Aryl(or heteroaryl)-5,6-dihydrobenzo[h]cinnolines as Potential Non-Covalent Multi-Targeting Inhibitors To Combat Neurodegenerative Diseases
    Hossein Mousavi, Mehdi Rimaz, Behzad Zeynizadeh · 2024 · ACS Chemical Neuroscience
  25. Molecular mechanisms and therapeutic strategies for neuromuscular diseases
    Alberto Andrea Zambon, Yuri Matteo Falzone, Alessandra Bolino, Stefano Carlo Previtali · 2024 · Cellular and Molecular Life Sciences
  26. Chemogenomics for drug discovery: clinical molecules from open access chemical probes
    Robert B. A. Quinlan, Paul E. Brennan · 2021 · RSC Chemical Biology
  27. RIP1 inhibition protects retinal ganglion cells in glaucoma models of ocular injury
    Bo Kyoung Kim, Tatiana Goncharov, Sébastien A. Archaimbault, Filip Roudnicky, Joshua D. Webster, Peter D. Westenskow, Domagoj Vucic · 2024 · Cell Death and Differentiation
  28. Sex-specific Tau methylation patterns and synaptic transcriptional alterations are associated with neural vulnerability during chronic neuroinflammation
    Alessandro Didonna, Ester Cantó, Hengameh Shams, Noriko Isobe, Chao Zhao, Stacy J. Caillier, Carlo Condello, Hana Yamate-Morgan, Seema Kaushalya Tiwari-Woodruff, Mohammad R. K. Mofrad et al. · 2019 · Journal of Autoimmunity
  29. Respiratory pathology in the Optn mouse model of Amyotrophic Lateral Sclerosis
    Angela L. McCall, Justin S. Dhindsa, Logan A. Pucci, Amanda F. Kahn, Anna F. Fusco, Debolina D. Biswas, Laura M. Strickland, Henry C. Tseng, Mai K. ElMallah · 2020 · Respiratory Physiology & Neurobiology
  30. RIP3 Contributes to Cardiac Hypertrophy by Influencing MLKL‐Mediated Calcium Influx
    Honghong Xue, Hongtao Shi, Fan Zhang, Hao Li, Chao Li, Qinghua Han · 2022 · Oxidative Medicine and Cellular Longevity
  31. Involvement of regulated cell deaths in aging and age-related pathologies
    Laura Della Torre, Antonio Beato, Vincenza Capone, Daniela Carannante, Giulia Verrilli, Gregorio Favale, Nunzio Del Gaudio, Wout Megchelenbrink, Rosaria Benedetti, Lucia Altucci et al. · 2024 · Ageing Research Reviews
  32. The necroptosis pathway and its role in age-related neurodegenerative diseases: will it open up new therapeutic avenues in the next decade?
    Natalia Salvadores, Felipe A. Court · 2020 · Expert Opinion on Therapeutic Targets
  33. Oligodendrocytes in amyotrophic lateral sclerosis and frontotemporal dementia: the new players on stage
    Marguerite Jamet, Luc Dupuis, José‐Luis González de Aguilar · 2024 · Frontiers in Molecular Neuroscience
  34. TAT-N24 enhances retinal ganglion cell survival by suppressing ZBP1-PANoptosome-mediated PANoptosis in an acute glaucoma mouse model
    Fei Li, Qiuxiang Zhang, Yan Rong, Sifei Xiang, Junming Wang · 2025 · Experimental Eye Research
  35. Quantitative analysis of phosphoproteome in necroptosis reveals a role of TRIM28 phosphorylation in promoting necroptosis-induced cytokine production
    Rui Zu, Zhen Yu, Jing Zhao, Xiaojuan Lu, Wei Ping Liang, Le Sun, Chenfang Si, Kezhou Zhu, Tian Zhang, Ganquan Li et al. · 2021 · Cell Death and Disease
  36. Receptor interacting protein 3 kinase, not 1 kinase, through MLKL-mediated necroptosis is involved in UVA-induced corneal endothelium cell death
    Zhen Yu, Nikolaos E. Efstathiou, Victor Correa, Xiaohong Chen, Kenji Ishihara, Yasuhiro Iesato, Toshio Narimatsu, Dimitrios P. Ntentakis, Yanyun Chen, Demetrios G. Vavvas · 2021 · Cell Death Discovery
  37. Viral-induced neuronal necroptosis: Detrimental to brain function and regulation by necroptosis inhibitors
    Siva Prasad Panda, Adarsh Kesharwani, Sarada Prasanna Mallick, DSNBK Prasanth, Praveen Kumar Pasala, Vinay Bharadwaj Tatipamula · 2023 · Biochemical Pharmacology
  38. Neuroprotective and anti-inflammatory effects of the RIPK3 inhibitor GSK872 in an MPTP-induced mouse model of Parkinson's disease
    Jin‐Sun Park, Yea‐Hyun Leem, Do‐Yeon Kim, Jae-Min Park, Seong‐Eun Kim, Hee-Sun Kim · 2024 · Neurochemistry International
  39. Coeloglossum viride var. bracteatum extract attenuates Aβ-induced toxicity by inhibiting RIP1–driven inflammation and necroptosis
    Xixi Li, Xiu-Yuan Lang, Teng-Teng Ren, Jun Wang, Rongfeng Lan, Xiao‐Yan Qin · 2021 · Journal of Ethnopharmacology
  40. Tristetraprolin regulates necroptosis during tonic Toll-like receptor 4 (TLR4) signaling in murine macrophages
    Ardeshir Ariana, Norah A. Alturki, Stephanie Hajjar, Deborah J. Stumpo, Christopher Tiedje, Emad S. Alnemri, Matthias Gaestel, Perry J. Blackshear, Subash Sad · 2020 · Journal of Biological Chemistry
  41. Cerebrospinal fluid cytotoxicity in amyotrophic lateral sclerosis: a systematic review of in vitro studies
    Koy Chong Ng Kee Kwong, Jenna M. Gregory, Suvankar Pal, Siddharthan Chandran, Arpan R. Mehta · 2020 · Brain Communications
  42. Immune Signaling Kinases in Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD)
    Raquel García-García, Laura Martín-Herrero, Laura Blanca-Pariente, Jesús A. Pérez-Cabello, Cintia Roodveldt · 2021 · International Journal of Molecular Sciences
  43. High mobility group box 1 enables bacterial lipids to trigger receptor-interacting protein kinase 3 (RIPK3)-mediated necroptosis and apoptosis in mice
    Ran Meng, Lan Gu, Yanyan Lu, Kai Zhao, Jianfeng Wu, Haichao Wang, Jiahuai Han, Yiting Tang, Ben Lü · 2019 · Journal of Biological Chemistry
  44. Predicting disease specific spinal motor neurons and glia in sporadic ALS
    Fabien Dachet, Jiangou Liu, John Ravits, Fei Song · 2019 · Neurobiology of Disease
  45. The diverse role of optineurin in pathogenesis of disease
    Qingyi Guo, Jincheng Wang, Qinjie Weng · 2020 · Biochemical Pharmacology
  46. Necroptosis at a glance
    Kidong Kang, Christa Park, Francis Ka-Ming Chan · 2022 · Journal of Cell Science
  47. Necroptosis Contributes to LPS-Induced Activation of the Hypothalamic-Pituitary-Adrenal Axis in a Piglet Model
    Bei Zhou, Qilong Xu, Junjie Guo, Qinliang Chen, Qingqing Lv, Kan Xiao, Huiling Zhu, Jiangchao Zhao, Yulan Liu · 2022 · International Journal of Molecular Sciences
  48. Motor axonopathies in a mouse model of Duchenne muscular dystrophy
    Justin S. Dhindsa, Angela L. McCall, Laura M. Strickland, Anna F. Fusco, Amanda F. Kahn, Mai K. ElMallah · 2020 · Scientific Reports
  49. Tuning Apoptosis and Neuroinflammation: TBK1 Restrains RIPK1
    Haiyang Yu, Don W. Cleveland · 2018 · Cell
  50. Genetic architecture of amyotrophic lateral sclerosis: a comprehensive review
    Lamei Yuan, Yuewen Yang, Yi Guo, Hao Deng · 2025 · Journal of genetics and genomics/Journal of Genetics and Genomics
  51. From RIPK1 to Necroptosis: Pathogenic Mechanisms in Neurodegenerative Diseases
    Anjuan Kang, Yujun Qiao, Shunli Pan, Fei Yan, Haile Chen, Yinliang Bai · 2025 · Neurochemical Research
  52. Single‐cell transcriptomics analysis of cellular heterogeneity and immune mechanisms in neurodegenerative diseases
    Ziping He, Qianqian Chen, Kaiyu Wang, Jiang Lin, Yilin Peng, Jinlong Zhang, Xi-Sheng Yan, Yan Jie · 2024 · European Journal of Neuroscience
  53. Axonopathy Underlying Amyotrophic Lateral Sclerosis: Unraveling Complex Pathways and Therapeutic Insights
    Tongshu Luan, Qing Li, Zhi Huang, Yu Feng, Duo Xu, Yujie Zhou, Yiqing Hu, Tong Wang · 2024 · Neuroscience Bulletin
  54. Progress in studies of necroptosis and its relationship to disease processes
    Zhen Wang, Limin Guo, Shu‐chao Wang, Dan Chen, Jie Yan, Fengxia Liu, Ju-fang Huang, Kun Xiong · 2018 · Pathology - Research and Practice
  55. Assessment of necroptosis in the retina in a repeated primary ocular blast injury mouse model
    Chloe N. Thomas, Ella F. Courtie, Alexandra Bernardo‐Colón, Gareth Essex, Tonia S. Rex, Zubair Ahmed, Richard James Blanch · 2020 · Experimental Eye Research
  56. An Iatrogenic Model of Brain Small-Vessel Disease: Post-Radiation Encephalopathy
    Rita Moretti, Paola Caruso · 2020 · International Journal of Molecular Sciences
  57. Kinase-Based Taming of Brain Microglia Toward Disease-Modifying Therapy
    Sun Hwa Lee, Kyoungho Suk · 2018 · Frontiers in Cellular Neuroscience
  58. Axonal Degeneration: RIPK1 Multitasking in ALS
    Kristin A. Politi, Serge Przedborski · 2016 · Current Biology
  59. Z-DNA-binding protein 1-mediated programmed cell death: Mechanisms and therapeutic implications
    Yuwei Huang, Lian Wang, Yanghui Zhu, Xiaoxue Li, Yingying Dai, Gu He, Xian Feng Jiang · 2025 · Chinese Medical Journal
  60. Optineurin Deficiency and Insufficiency Lead to Higher Microglial TDP-43 Protein Levels
    Nikolina Prtenjača, Matea Rob, Muhammad Shamsul Alam, Andrea Markovinović, Cristiana Stuani, Emanuele Buratti, Ivana Munitić · 2022 · International Journal of Molecular Sciences
  61. UVA induces retinal photoreceptor cell death via receptor interacting protein 3 kinase mediated necroptosis
    Zhen Yu, Victor Correa, Nikolaos E. Efstathiou, Henar Albertos‐Arranz, Xiaohong Chen, Kenji Ishihara, Yasuhiro Iesato, Toshio Narimatsu, Dimitrios P. Ntentakis, Demetrios G. Vavvas · 2022 · Cell Death Discovery
  62. High-fat diet exacerbates 1-Bromopropane-induced loss of dopaminergic neurons in the substantia nigra of mice through mitochondrial damage associated necroptotic pathway
    Mingxue Song, Yalong Qiang, Shuai Wang, Shan Shan, Liwen Zhang, Caipei Liu, Fuyong Song, Xiulan Zhao · 2024 · Ecotoxicology and Environmental Safety
  63. The interplay between α-synuclein aggregation and necroptosis in Parkinson’s disease: a spatiotemporal perspective
    Haoran Xiang · 2025 · Frontiers in Neuroscience
  64. Die in pieces: How Drosophila sheds light on neurite degeneration and clearance
    Maria L. Sapar, Chun Han · 2019 · Journal of genetics and genomics/Journal of Genetics and Genomics
  65. Exploring necroptosis: mechanistic analysis and antitumor potential of nanomaterials
    Jiaheng Dong, Jiale Zhang, Kunhou Yao, Xiao Li Xu, Yaqi Zhou, Lei Zhang, Changjiang Qin · 2025 · Cell Death Discovery
  66. RIPK1 signaling pathways: implications for autoimmune and neuroinflammatory diseases
    Abigail Pajulas, Jonathan T. Sims, Eric Paul Hanson, Andrew C. Vendel · 2025 · Frontiers in Immunology
  67. Radiosynthesis and characterization of a carbon-11 PET tracer for receptor-interacting protein kinase 1
    Tianyu Huang, Jiwei Gu, Hao Jiang, Qianwa Liang, Joel S. Perlmutter, Zhude Tu · 2022 · Nuclear Medicine and Biology
  68. OPTN variants in ALS cases: a case report of a novel mutation and literature review
    Yan Mou, Min Li, Mengling Liu, Jia Wang, Guofeng Zhu, Yunhong Zha · 2022 · Neurological Sciences
  69. Structure-Based Design of Novel Alkynyl Thio-Benzoxazepinone Receptor-Interacting Protein Kinase-1 Inhibitors: Extending the Chemical Space from the Allosteric to ATP Binding Pockets
    Danni Quan, Ruilin Hou, Hongming Shao, Xinqi Zhang, Jianqiang Yu, Wannian Zhang, Hongbin Yuan, Chunlin Zhuang · 2023 · Journal of Medicinal Chemistry
  70. Stressor control and regional inflammatory responses in the brain: regulation by the basolateral amygdala
    Austin M. Adkins, Emily M. Colby, Woong‐Ki Kim, Laurie L. Wellman, Larry D. Sanford · 2023 · Journal of Neuroinflammation
  71. TAK1 Reduces Surgery-induced Overactivation of RIPK1 to Relieve Neuroinflammation and Cognitive Dysfunction in Aged Rats
    Yuhan Zhang, Su Yang, Ziheng Wang, Teng Li, Liwei Wang, Daqing Ma, Meiyan Zhou · 2023 · Neurochemical Research
  72. Elevated α5 integrin expression on myeloid cells in motor areas in amyotrophic lateral sclerosis is a therapeutic target
    Aude Chiot, Shanu Faerch Roemer, Lisa C. Ryner, Alina P. Bogachuk, Katie Emberley, Dillon Brownell, Gisselle A. Jimenez, Michael W. Leviten, Randall L. Woltjer, Dennis W. Dickson et al. · 2023 · Proceedings of the National Academy of Sciences
  73. Mechanism of motoneuronal and pyramidal cell death in amyotrophic lateral sclerosis and its potential therapeutic modulation
    Bernát Nógrádi, Dóra Nógrádi-Halmi, Barbara Erdélyi-Furka, Zalán Kádár, Tamás Csont, Renáta Gáspár · 2024 · Cell Death Discovery
  74. Promising animal models for amyotrophic lateral sclerosis drug discovery: a comprehensive update
    Léa Lescouzères, Shunmoogum A. Patten · 2024 · Expert Opinion on Drug Discovery
  75. Safety, Pharmacokinetics and Target Engagement of a Novel Brain Penetrant RIPK1 Inhibitor ( SIR9900 ) in Healthy Adults and Elderly Participants
    Ofer Michael Gonen, Tim Porter, Buwei Wang, Fenchao Xue, Yongfen Ma, Linan Song, Pei Sun, Weiliang Fan, Yang Shen · 2025 · Clinical and Translational Science
  76. Three-Dimensional Motor Nerve Organoid Generation
    Tatsuya Osaki, Siu Yu A. Chow, Yui Nakanishi, Joel Hernández, Jiro Kawada, Teruo Fujii, Yoshiho Ikeuchi · 2020 · Journal of Visualized Experiments
  77. A New Perspective on The Potential Application of Ripk1 in the Treatment of Sepsis
    Xuesong Wang, Yan Chai, Zhe Guo, Ziyi Wang, Haiyan Liao, Ziwen Wang, Zhong Wang · 2023 · Immunotherapy
  78. Necrostatin-1s Suppresses RIPK1-driven Necroptosis and Inflammation in Periventricular Leukomalacia Neonatal Mice
    Jinping Sun, Wei Wang, Quanrui Ma, Xiaoli Pan, Hualiang Zhai, Junyan Wang, Yong Han, Yunhong Li, Yin Wang · 2023 · Neurochemical Research
  79. Intercellular propagation of RIPK1/RIPK3 amyloid fibrils
    Yeyang Ma, Qiuyuan Zhang, Dekang Li, Kun Zhao, Zefei Li, Yuan Liu, Chu Wang, Bo Sun, Dan Li, Junying Yuan et al. · 2025 · Proceedings of the National Academy of Sciences
  80. Die hard: necroptosis and its impact on age-dependent neuroinflammatory diseases
    Kaitlan Smith, Meagan Colie, Trinity Moore, Jonathan Cummings Schisler · 2024 · Frontiers in Cell Death
  81. Microtubules, Membranes, and Movement: New Roles for Stathmin‐2 in Axon Integrity
    Emma J. C. Thornburg‐Suresh, Daniel W. Summers · 2024 · Journal of Neuroscience Research
  82. Wnt signaling induces neurite outgrowth in mouse retinal ganglion cells
    Adanna Udeh, Galina Dvoriantchikova, Tal Carmy, Dmitry Ivanov, Abigail S. Hackam · 2019 · Experimental Eye Research
  83. SHARPIN: Role in Finding NEMO and in Amyloid-Beta Clearance and Degradation (ABCD) Pathway in Alzheimer’s Disease?
    Dhanya Krishnan, Ramshekhar N. Menon, Srinivas Gopala · 2021 · Cellular and Molecular Neurobiology
  84. Scaffold hopping derived novel benzoxazepinone RIPK1 inhibitors as anti-necroptosis agents
    Jiaqin Tang, Yanran Wu, Wenli Zhao, Zhuo Qu, Jianqiang Yu, Zhizhong Wang, Ying Shi · 2023 · Bioorganic & Medicinal Chemistry
  85. Cognitive impairments induced by severe acute pancreatitis are attenuated by berberine treatment in rats
    Xiaofeng Ou, Yusi Hua, Xuelian Liao, Cansheng Gong, Yan Ming Kang · 2018 · Molecular Medicine Reports
  86. Repurposing of the FGFR inhibitor AZD4547 as a potent inhibitor of necroptosis by selectively targeting RIPK1
    Zuowei Wang, Fengming Zou, Aoli Wang, Jing Chun Yang, Rui Jin, Beilei Wang, Lijuan Shen, Shuang Qi, Juan Liu, Qingsong Liu et al. · 2022 · Acta Pharmacologica Sinica
  87. Identification and validation of prognostic and tumor microenvironment characteristics of necroptosis index and BIRC3 in clear cell renal cell carcinoma
    Kai Wei, Xi Zhang, Dongrong Yang · 2023 · PeerJ
  88. Development of a New Positron Emission Tomography Imaging Radioligand Targeting RIPK1 in the Brain and Characterization in Alzheimer's Disease
    Ping Bai, Yu Lan, Yan Liu, Prasenjit Mondal, Ashley Gomm, Yulong Xu, Yanli Wang, Yongle Wang, Leyi Kang, Lili Pan et al. · 2024 · Advanced Science
  89. Ca2+ transfer via enhancing ER-Mito coupling contributed to BDE-47- induced hippocampal neuronal necroptosis and cognitive dysfunction
    Junhong Geng, Quan Yuan, Chaofang Ni, Yarong Zhang, Xiaoli Liu, Xiaoying Zhu, Xueqin Hao, Gaofeng Liang, Dongmei Wang, Hua Fan · 2025 · Ecotoxicology and Environmental Safety
  90. Noncanonical cell death program independent of caspase activation cascade and necroptotic modules is elicited by loss of TGFβ-activated kinase 1
    September R. Mihaly, Yosuke Sakamachi, Jun Ninomiya‐Tsuji, Sho Morioka · 2017 · Scientific Reports
  91. Analyzing hedyotis diffusa mechanisms of action from the genomics perspective
    Chenjun Hu, Ju He, Guozheng Li, Peipei Fang, Jiadong Xie, Youwei Ding, Yuqing Mao, Kongfa Hu · 2018 · Computer Methods and Programs in Biomedicine
  92. Regulated proteolysis as an element of ER stress and autophagy: Implications for intestinal inflammation
    Stephanie T. Stengel, Berith Messner, Maren Falk‐Paulsen, Nina Sommer, Philip C Rosenstiel · 2017 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
  93. Furosine, a Maillard Reaction Product, Triggers Necroptosis in Hepatocytes by Regulating the RIPK1/RIPK3/MLKL Pathway
    Huiying Li, Yizhen Wang, Huaigu Yang, Yangdong Zhang, Lei Xing, Jiaqi Wang, Nan Zheng · 2019 · International Journal of Molecular Sciences
  94. Cell Death-Osis of Dopaminergic Neurons and the Role of Iron in Parkinson's Disease
    Illyane Sofia Lima, Ana Catarina Pêgo, João Tomás Barros, Ana Rita Prada, Raffaella Gozzelino · 2020 · Antioxidants and Redox Signaling
  95. Necroptosis in ALS: a hot topic in-progress
    Mathilde Chevin, Guillaume Sébire · 2021 · Cell Death Discovery
  96. Repression of RIPK1 kinase by INPP5D inhibits expression of diverse proinflammatory mediators and late-onset Alzheimer’s disease risk factors
    Xingxing Xie, Jianping Liu, Wei Liang, Yici Zhang, Xueqi Gong, Shenghao Yuan, Chunting Qi, Maoqing Huang, Linyu Shi, Meiling Hou et al. · 2026 · Immunity
  97. Evaluating the causal association between microRNAs and amyotrophic lateral sclerosis
    Yahui Zhu, Li Mao, Zhengqing He, Xinyuan Pang, Rongrong Du, Wenxiu Yu, Jinghong Zhang, Jiongming Bai, Jiao Wang, Xusheng Huang · 2023 · Neurological Sciences
  98. Inflammatory cytokines disrupt astrocyte exosomal HepaCAM-mediated protection against neuronal excitotoxicity in the SOD1G93A ALS model
    Shijie Jin, Yang Tian, Jonathan Hacker, Xuan Chen, Marcela Bertolio, Caroline R. Reynolds, Rachel Jarvis, Jingwen Hu, Vanessa Promes, Dilara Ozge Halim et al. · 2024 · Science Advances
  99. Exploring the Role of Axons in ALS from Multiple Perspectives
    Xiaosu Chen, Shujun Lv, Jinmeng Liu, Yingjun Guan, Chunjie Xu, Xiaonan Ma, Mu Li, Xue Bai, Kexin Liu, Haoyun Zhang et al. · 2024 · Cells
  100. Targeting necroptosis in Alzheimer’s disease: can exercise modulate neuronal death?
    Di Lu, Wenyu Zhang, Ruiyu Li, Sijie Tan, Yan Zhang · 2025 · Frontiers in Aging Neuroscience